 Nucleotide analogues require only two phosphorylation steps whereas nucleoside analogues require three steps.Reduction in the phosphorylation requirement may allow more rapid and complete conversion of drugs to their active metabolites.Such considerations have led to the development of phosphonate nucleotide analogues such as tenofovir.